TIDMBII

RNS Number : 8292Z

Pendragon Capital LLP

20 January 2011

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

 
     (a) Identity of the person whose         Pendragon Capital LLP 
     positions/dealings are being 
     disclosed: 
-------------------------------------------  --------------------------------- 
     (b) Owner or controller of interests 
     and short positions disclosed, if 
     different from 1(a): The naming of 
     nominee or vehicle companies is 
     insufficient 
-------------------------------------------  --------------------------------- 
     (c) Name of offeror/offeree in           Biocompatibles International Plc 
     relation to whose relevant securities 
     this form relates: Use a separate form 
     for each offeror/offeree 
-------------------------------------------  --------------------------------- 
     (d) If an exempt fund manager 
     connected with an offeror/offeree, 
     state this and specify identity of 
     offeror/offeree: 
-------------------------------------------  --------------------------------- 
     (e) Date position held/dealing           19 January 2011 
     undertaken: 
-------------------------------------------  --------------------------------- 
     (f) Has the discloser previously         YES 
     disclosed, or are they today 
     disclosing, under the Code in respect 
     of any other party to this offer? 
-------------------------------------------  --------------------------------- 
 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
 Class of relevant security: 
---------------------------------------  ------------------------------------- 
                                             Interests        Short positions 
---------------------------------------  -----------------  ------------------ 
                                           Number      %        Number      % 
---------------------------------------  ----------  -----  -------------  --- 
     (1) Relevant securities owned 
     and/or controlled: 
---------------------------------------  ----------  -----  -------------  --- 
     (2) Derivatives (other than 
      options):                           1,332,089   3.38 
---------------------------------------  ----------  -----  -------------  --- 
     (3) Options and agreements to 
     purchase/sell: 
---------------------------------------  ----------  -----  -------------  --- 
     TOTAL:                               1,332,089   3.38 
---------------------------------------  ----------  -----  -------------  --- 
 

All interests and all short positions should be disclosed.

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other executive options)

 
 Class of relevant security in relation to which subscription 
  right exists: 
------------------------------------------------------------- 
 Details, including nature of the rights concerned 
  and relevant percentages: 
------------------------------------------------------------- 
 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c) copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a) Purchases and sales

 
   Class of relevant     Purchase/sale   Number of securities   Price per unit 
       security 
----------------------  --------------  ---------------------  --------------- 
 
 

(b) Derivatives transactions (other than options)

 
  Class of       Product       Nature of dealing     Number of     Price per 
  relevant     description           e.g.            reference        unit 
  security       e.g. CFD      opening/closing a    securities 
                                  long/short 
                                   position, 
                              increasing/reducing 
                                 a long/short 
                                   position 
------------  -------------  --------------------  ------------  ------------- 
  Ordinary         CFD        Increasing a long       105,520       397.17p 
                              position 
------------  -------------  --------------------  ------------  ------------- 
 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 
 Class of     Product      Writing,     Number of    Exercise   Type e.g.   Expiry    Option 
 relevant   description   purchasing,   securities    price     American,    date     money 
 security    e.g. call     selling,      to which      per      European              paid/ 
              option        varying       option       unit       etc.               received 
                             etc.        relates                                       per 
                                                                                       unit 
---------  ------------  ------------  -----------  ---------  ----------  -------  --------- 
 
 

(ii) Exercising

 
 Class of relevant        Product            Number of        Exercise price 
     security        description e.g.       securities           per unit 
                        call option 
------------------  ------------------  ------------------  ------------------ 
 
 

(d) Other dealings (including subscribing for new securities)

 
   Class of relevant      Nature of dealing     Details    Price per unit (if 
       security           e.g. subscription,                  applicable) 
                              conversion 
----------------------  ---------------------  --------  --------------------- 
 
 

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b) (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

 
 Details of any indemnity or option arrangement, or 
  any agreement or understanding, formal or informal, 
  relating to relevant securities which may be an inducement 
  to deal or refrain from dealing entered into by the 
  person making the disclosure and any party to the 
  offer or any person acting in concert with a party 
  to the offer: 
  If there are no such agreements, arrangements or understandings, 
  state "none" 
------------------------------------------------------------------ 
 None 
------------------------------------------------------------------ 
 

(b) Agreements, arrangements or understandings relating to options or derivatives

 
     Details of any agreement, arrangement or understanding, 
      formal or informal, between the person making the 
      disclosure and any other person relating to: 
      (i) the voting rights of any relevant securities under 
      any option; or 
     (ii) the voting rights or future acquisition or disposal 
      of any relevant securities to which any derivative 
      is referenced: 
      If there are no such agreements, arrangements or understandings, 
      state "none" 
---------------------------------------------------------------------- 
 None 
---------------------------------------------------------------------- 
 

(c) Attachments

 
 Is a Supplemental Form 8 (Open Positions) attached?   NO 
----------------------------------------------------  --- 
 
 
 Date of disclosure:    20 January 2011 
---------------------  ----------------- 
 Contact name:          Kathy Samii 
---------------------  ----------------- 
 Telephone number:      +44 20 7355 0420 
---------------------  ----------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETURASRARAAUAR

Biocompatibles (LSE:BII)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024 Biocompatibles 차트를 더 보려면 여기를 클릭.
Biocompatibles (LSE:BII)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024 Biocompatibles 차트를 더 보려면 여기를 클릭.